Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually administered products, such as melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide product. In addition, it is developing formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and other classes of drugs through sublingual administration; and caffeine products, such as a formula for a single dose sublingual pre-workout supplement. The company was founded in 2021 and is headquartered in Estero, Florida.
Frequently asked questions
What sector does Aspire BioPharma, Inc. (ASBP) operate in?
Aspire BioPharma, Inc. belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Aspire BioPharma, Inc. (ASBP) current stock price?
As of the latest data, Aspire BioPharma, Inc. stock price is $7.85, with a previous close of $7.11. Aspire BioPharma, Inc. gained $0.74 in the last trading session, representing a 10.41% increase.
What is Aspire BioPharma, Inc. (ASBP) current market capitalization?
Aspire BioPharma, Inc. market cap is approximately 10.17 million.
What is Aspire BioPharma, Inc. (ASBP) Earnings Per Share (EPS)?
The trailing EPS is -$6.98.
What is Aspire BioPharma, Inc. (ASBP) EBITDA?
Aspire BioPharma, Inc. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -62.28 thousand.
Does Aspire BioPharma, Inc. (ASBP) pay dividends?
No. Aspire BioPharma, Inc. does not pay a dividend.
When is Aspire BioPharma, Inc. (ASBP) next earnings report?
Aspire BioPharma, Inc. is expected to release its next earnings report on June 30, 2026.
What is Aspire BioPharma, Inc. (ASBP) beta (volatility) score?
Aspire BioPharma, Inc. has a beta of 0.111, indicating lower volatility than the overall market.
